Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Delayed Quote USD

Hims & Hers Health, Inc. (HIMS)

Compare
25.99
-2.00
(-7.15%)
At close: April 4 at 4:00:02 PM EDT
25.45
-0.54
(-2.08%)
After hours: April 4 at 7:59:58 PM EDT
Loading Chart for HIMS
  • Previous Close 27.99
  • Open 26.30
  • Bid 25.17 x 1000
  • Ask 25.55 x 900
  • Day's Range 23.97 - 27.09
  • 52 Week Range 11.20 - 72.98
  • Volume 27,541,928
  • Avg. Volume 23,332,608
  • Market Cap (intraday) 5.774B
  • Beta (5Y Monthly) 1.65
  • PE Ratio (TTM) 49.04
  • EPS (TTM) 0.53
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 44.16

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

www.hims.com

1,637

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HIMS

View More

Performance Overview: HIMS

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HIMS
7.49%
S&P 500 (^GSPC)
13.73%

1-Year Return

HIMS
77.04%
S&P 500 (^GSPC)
1.42%

3-Year Return

HIMS
371.69%
S&P 500 (^GSPC)
10.72%

5-Year Return

HIMS
164.13%
S&P 500 (^GSPC)
103.89%

Compare To: HIMS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HIMS

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    5.77B

  • Enterprise Value

    5.49B

  • Trailing P/E

    49.04

  • Forward P/E

    43.67

  • PEG Ratio (5yr expected)

    2.45

  • Price/Sales (ttm)

    4.17

  • Price/Book (mrq)

    12.11

  • Enterprise Value/Revenue

    3.71

  • Enterprise Value/EBITDA

    69.44

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.54%

  • Return on Assets (ttm)

    7.18%

  • Return on Equity (ttm)

    30.71%

  • Revenue (ttm)

    1.48B

  • Net Income Avi to Common (ttm)

    126.04M

  • Diluted EPS (ttm)

    0.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    300.25M

  • Total Debt/Equity (mrq)

    2.38%

  • Levered Free Cash Flow (ttm)

    178.69M

Research Analysis: HIMS

View More

Company Insights: HIMS

Research Reports: HIMS

View More

People Also Watch